1. Home
  2. TELO vs ACOG Comparison

TELO vs ACOG Comparison

Compare TELO & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELO
  • ACOG
  • Stock Information
  • Founded
  • TELO 2021
  • ACOG 2000
  • Country
  • TELO United States
  • ACOG Canada
  • Employees
  • TELO N/A
  • ACOG N/A
  • Industry
  • TELO
  • ACOG
  • Sector
  • TELO
  • ACOG
  • Exchange
  • TELO NYSE
  • ACOG Nasdaq
  • Market Cap
  • TELO 79.2M
  • ACOG 80.3M
  • IPO Year
  • TELO 2024
  • ACOG N/A
  • Fundamental
  • Price
  • TELO $2.01
  • ACOG $9.67
  • Analyst Decision
  • TELO
  • ACOG Strong Buy
  • Analyst Count
  • TELO 0
  • ACOG 1
  • Target Price
  • TELO N/A
  • ACOG $20.00
  • AVG Volume (30 Days)
  • TELO 217.3K
  • ACOG 188.2K
  • Earning Date
  • TELO 05-14-2025
  • ACOG 05-15-2025
  • Dividend Yield
  • TELO N/A
  • ACOG N/A
  • EPS Growth
  • TELO N/A
  • ACOG N/A
  • EPS
  • TELO N/A
  • ACOG N/A
  • Revenue
  • TELO N/A
  • ACOG $2,928,654.00
  • Revenue This Year
  • TELO N/A
  • ACOG N/A
  • Revenue Next Year
  • TELO N/A
  • ACOG N/A
  • P/E Ratio
  • TELO N/A
  • ACOG N/A
  • Revenue Growth
  • TELO N/A
  • ACOG N/A
  • 52 Week Low
  • TELO $1.87
  • ACOG $3.75
  • 52 Week High
  • TELO $8.40
  • ACOG $11.40
  • Technical
  • Relative Strength Index (RSI)
  • TELO 37.33
  • ACOG N/A
  • Support Level
  • TELO $1.88
  • ACOG N/A
  • Resistance Level
  • TELO $2.19
  • ACOG N/A
  • Average True Range (ATR)
  • TELO 0.19
  • ACOG 0.00
  • MACD
  • TELO 0.01
  • ACOG 0.00
  • Stochastic Oscillator
  • TELO 19.18
  • ACOG 0.00

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: